賽為智能(300044.SZ):目前的主推產品種類有無人機產品等
格隆匯11月22日丨賽為智能(300044.SZ)近期在接待機構投資者調研時表示,賽為智能成立於1997年,隨着工業自動化發展成長起來;2000至2010年,公司進入集成時代,開拓了建築智能化、軌道交通智能化、智慧城市等集成領域的業務;2015年後,公司逐步在人工智能領域加大投入,增加算法團隊規模,聚焦深度學習圖像技術,並在此基礎上衍生出無人機和機器人產品,轉變成了以提供工業機器視覺為核心技術綜合性解決方案的公司。公司目前的主推產品種類有無人機產品、巡檢機器人產品、以機器視覺為核心技術的平台軟件產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.